Selecting a Foundation Model of Transcription Across Human Cell Types

The Shift to Large-Scale Transcriptomic AI

The exponential growth of single-cell RNA sequencing (scRNA-seq) has generated atlases comprising tens of millions of cells, rendering traditional statistical methods insufficient for capturing complex, non-linear gene regulatory networks. In response, the field has pivoted toward large-scale transformer architectures. When evaluating a foundation model of transcription across human cell types, computational biologists must navigate a rapidly fragmenting landscape of architectures, pre-training objectives, and tokenization strategies. Selecting the optimal model is no longer about picking the largest parameter count; it requires a rigorous selection framework aligned with specific downstream tasks, input data sparsity, and available compute infrastructure.

Core Contenders in the 2026 Landscape

The current ecosystem is dominated by three primary architectural paradigms, each utilizing distinct methods to convert continuous transcriptomic counts into discrete or continuous token embeddings. Understanding these differences is the first step in the selection framework.

As detailed in the foundational literature, models like Geneformer utilize a rank-based tokenization strategy that inherently normalizes for sequencing depth, making it highly robust across disparate Theodoris et al. (Nature, 2023) datasets. Conversely, scGPT employs binned expression values combined with masked language modeling, a paradigm borrowed from natural language processing that excels in generative and imputation tasks, as demonstrated by Cui et al. (Nature Methods, 2024).

A Task-Driven Selection Framework

Rather than defaulting to the most recent release, researchers should apply a decision matrix based on their primary downstream objective.

1. Cell Type Annotation and Rare Population Discovery

Recommended Model: Geneformer or scFoundation.

• Why: Rank-value and read-depth-aware encodings preserve the relative stoichiometry of gene expression, which is critical for distinguishing subtle transcriptional gradients in rare progenitor cells.
• Implementation Tip: For zero-shot annotation, extract the [CLS] token embedding and apply a lightweight k-nearest neighbors (k-NN) classifier. This avoids the catastrophic forgetting associated with full fine-tuning on small, biased target datasets.

2. In Silico Gene Perturbation and CRISPR Screening

Recommended Model: scFoundation.

• Why: Predicting the downstream effects of gene knockouts requires a model that understands absolute transcript counts and read-depth context, not just relative ranks. scFoundation's architecture explicitly models total UMI counts, allowing for accurate simulation of transcriptional amplification or suppression post-perturbation.
• Edge Case: If simulating essential gene knockouts that trigger apoptosis, ensure the model's latent space is augmented with cell-cycle regression priors to prevent confounding death-signatures with direct regulatory targets.

3. Multi-Omic Integration (Spatial + scRNA-seq)

Recommended Model: scGPT.

• Why: scGPT's binned tokenization is highly adaptable to cross-modal alignment. When mapping dissociated scRNA-seq data onto 10x Genomics Visium or Xenium spatial slides, scGPT's masked modeling objective allows for seamless imputation of spatial dropouts.

Evaluating Sparsity and Dropout Tolerance

A major point of failure in applying these models is mismatching the model's pre-training sparsity assumptions with the inference data. Standard 10x Genomics Chromium runs exhibit dropout rates exceeding 80% for lowly expressed transcription factors.

Models trained on heavily imputed or aggregated 'pseudo-bulk' data will systematically misclassify sparse, high-quality single-cell profiles by interpreting biological zeros as technical dropouts. Always verify the pre-training pipeline's handling of zero-inflation.

For highly sparse datasets (e.g., single-nucleus RNA-seq from archived brain tissue), Geneformer's rank-based approach is vastly superior. Because it only processes the top N detected genes per cell, it is entirely immune to the noise introduced by massive technical zero-inflation, focusing purely on the most biologically informative transcripts.

Hardware Constraints and Fine-Tuning Efficacy

Deploying a foundation model of transcription across human cell types requires significant VRAM, particularly when moving beyond inference to task-specific fine-tuning.

• Inference Only: Most 100M-parameter models can run on a single NVIDIA RTX 4090 (24GB VRAM) using batch sizes of 32-64 cells, processing 100,000 cells in under 15 minutes.
• Full Fine-Tuning: Requires NVIDIA A100 (80GB) or H100 clusters. Processing a 1-million cell atlas for 5 epochs will take approximately 14-18 hours on a single A100.
• Parameter-Efficient Fine-Tuning (PEFT): Utilizing Low-Rank Adaptation (LoRA) or QLoRA (4-bit quantization) reduces VRAM requirements by up to 70%. This allows researchers to fine-tune massive 1B-parameter models on consumer-grade hardware or single cloud instances without significant degradation in downstream accuracy.

Decision Matrix: When to Fine-Tune vs. Zero-Shot

Do not default to fine-tuning. Fine-tuning a 6-layer transformer on a dataset of fewer than 5,000 cells will result in severe overfitting, effectively destroying the generalized biological priors learned during pre-training.

Summary of Best Practices

Selecting the right architecture requires aligning the model's tokenization strategy with your data's noise profile and your hardware's memory constraints. For rank-based robustness and zero-shot annotation, Geneformer remains the gold standard. For absolute count simulation and perturbation modeling, scFoundation provides unmatched contextual depth. By applying this task-driven framework, researchers can bypass the hype cycle and deploy transcriptomic AI that yields reproducible, biologically valid insights.